We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$599M
AUM Growth
+$99.2M
(+20%)
Cap. Flow
+$49.8M
Cap. Flow
% of AUM
8.31%
Top 10 Holdings %
Top 10 Hldgs %
34.81%
Holding
710
New
83
Increased
162
Reduced
252
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$19.1M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$14.1M |
| 3 |
iShares MSCI Turkey ETF
TUR
|
+$14M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$10.8M |
| 5 |
iShares MSCI Thailand ETF
THD
|
+$9.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$16.7M |
| 2 |
Rogers Communications
RCI
|
+$6.28M |
| 3 |
TechnipFMC
FTI
|
+$5.75M |
| 4 |
PepsiCo
PEP
|
+$4.71M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 9.52% |
| 2 | Financials | 9.27% |
| 3 | Communication Services | 8.11% |
| 4 | Technology | 7.63% |
| 5 | Materials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Corpay
CPAY
$24.2B
| $1.26M | 0.21% |
5,977
+5,974
| +199,133% | +$1.23M |
|
|
PPL
102
PPL Corp
PPL
$27.3B
| $1.25M | 0.21% |
43,908
-6,343
| -13% | -$176K |
|
103
McDonald's
MCD
$188B
| $1.25M | 0.21% |
7,966
-2,905
| -27% | -$471K |
|
104
TJX Companies
TJX
$170B
| $1.23M | 0.21% |
25,954
-3,138
| -11% | -$138K |
|
105
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $1.22M | 0.2% |
11,875
-1,357
| -10% | -$138K |
|
106
Alibaba
BABA
$269B
| $1.22M | 0.2% |
6,559
+1,160
| +21% | +$221K |
|
|
HDS
107
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.21M | 0.2% |
28,269
+28,268
| +2,826,800% | +$1.14M |
|
108
Occidental Petroleum
OXY
$57B
| $1.21M | 0.2% |
14,442
+13,597
| +1,609% | +$1.09M |
|
109
Fortinet
FTNT
$112B
| $1.2M | 0.2% |
96,530
-23,855
| -20% | -$283K |
|
110
HCA Healthcare
HCA
$84.8B
| $1.2M | 0.2% |
11,704
-356
| -3% | -$36K |
|
|
SEE
111
DELISTED
Sealed Air
SEE
| $1.19M | 0.2% |
+28,019
| New | +$1.23M |
|
112
Expeditors International
EXPD
$22.9B
| $1.19M | 0.2% |
+16,238
| New | +$1.13M |
|
113
Global Payments
GPN
$22.1B
| $1.18M | 0.2% |
10,603
+10,597
| +176,617% | +$1.2M |
|
114
CDW
CDW
$17.1B
| $1.17M | 0.2% |
+14,488
| New | +$1.12M |
|
115
Pultegroup
PHM
$24.5B
| $1.14M | 0.19% |
39,714
+39,678
| +110,217% | +$1.19M |
|
116
Ulta Beauty
ULTA
$20.4B
| $1.12M | 0.19% |
+4,805
| New | +$1.16M |
|
117
Martin Marietta Materials
MLM
$33.6B
| $1.12M | 0.19% |
4,983
-943
| -16% | -$201K |
|
|
RTN
118
DELISTED
Raytheon Company
RTN
| $1.12M | 0.19% |
+5,777
| New | +$1.21M |
|
|
UN
119
DELISTED
Unilever NV New York Registry Shares
UN
| $1.12M | 0.19% |
20,013
+17,870
| +834% | +$1,000K |
|
120
American Electric Power
AEP
$73.7B
| $1.11M | 0.19% |
16,036
-5,965
| -27% | -$402K |
|
121
Fluor
FLR
$7.29B
| $1.09M | 0.18% |
22,163
+21,083
| +1,952% | +$1.1M |
|
122
AbbVie
ABBV
$458B
| $1.08M | 0.18% |
11,666
-19,688
| -63% | -$1.92M |
|
|
FNSR
123
DELISTED
Finisar Corp
FNSR
| $1.08M | 0.18% |
59,911
+7,191
| +14% | +$119K |
|
|
KL
124
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $1.07M | 0.18% |
51,000
-13,000
| -20% | -$238K |
|
125
SSR Mining
SSRM
$5.57B
| $1.07M | 0.18% |
108,672
+29,747
| +38% | +$303K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2018 Portfolio in Review
As of Q2 2018, Exane Derivatives held 710 positions worth $599M, up 20% from $500M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Exane Derivatives deployed $49.8M of net new capital in Q2 2018, opening 83 new positions and adding to 162 existing holdings. Its largest new stake was UBS Group: 1,172,516 shares worth $18.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $16.7M trimmed.
- Exane Derivatives's largest Q2 2018 buy was UBS Group: 1,172,516 shares worth $18.1M.
- Exane Derivatives added most to VanEck Russia ETF in Q2 2018, an estimated $14.1M increase.
- Exane Derivatives's biggest Q2 2018 reduction was Freeport-McMoran, cutting an estimated $16.7M.
- Exane Derivatives fully exited Rogers Communications in Q2 2018, selling an estimated $6.28M.
- Exane Derivatives's ten largest holdings make up 35% of its $599M portfolio in Q2 2018.
- Exane Derivatives opened 83 new positions and closed 24 in Q2 2018.
- Exane Derivatives's portfolio value rose 20% quarter-over-quarter to $599M.
Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.